Karyopharm Therapeutics Inc. (KPTI)

NASDAQ: KPTI · Real-Time Price · USD

2.000

+0.070 (3.63%)

At close: Aug 19, 2026, 4:00 PM EDT

2.000

0.00 (0.00%)

After-hours: Aug 19, 2026, 6:14 PM EDT

Karyopharm Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-224.74	-196.04	-76.42	-143.1	-165.29	-124.09
Depreciation & Amortization	0.15	0.3	0.34	0.53	0.62	0.79
Other Amortization	10.17	10.55	6.37	0.81	0.81	0.78
Asset Writedown & Restructuring Costs	-	-	-	-	-	7.36
Loss (Gain) From Sale of Investments	-0.14	-0.41	-2.5	-4.1	-0.83	1.56
Stock-Based Compensation	11.64	14.05	18.43	21.71	35.4	29.78
Other Operating Activities	112.7	67.92	-73.39	-	-0.28	-0.11
Change in Accounts Receivable	3.06	4.59	-3.8	20.12	-5.08	-9.62
Change in Inventory	1	0.7	-1.7	1.18	-0.12	-1.46
Change in Accounts Payable	5.06	-1.1	1.98	0.35	1.17	-2.85
Change in Other Net Operating Assets	15.75	24.09	3.21	9.77	-15.96	-9.26
Operating Cash Flow	-65.35	-75.37	-127.49	-92.72	-149.55	-107.12
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-	-	-0.14	-	-0.12	-0.21
Sale (Purchase) of Intangibles	-	-	-	-	-	-5.5
Investment in Securities	2.97	43.38	95.62	7.94	-104.14	147.55
Investing Cash Flow	2.97	43.38	95.47	7.94	-104.26	141.84
Long-Term Debt Issued	-	27.25	83.3	-	-	-
Long-Term Debt Repaid	-	-0.25	-	-	-	-
Net Debt Issued (Repaid)	27	27	83.3	-	-	-
Issuance of Common Stock	59.96	9.51	1.45	1.12	193.74	13.65
Other Financing Activities	-8.37	-6.46	-43.11	-	-	60
Financing Cash Flow	78.6	30.05	41.65	1.12	193.74	73.65
Foreign Exchange Rate Adjustments	0.01	0.02	-0.01	-0.03	-0.49	-0.05
Net Cash Flow	16.22	-1.92	9.62	-83.69	-60.56	108.32
Free Cash Flow	-65.35	-75.37	-127.63	-92.72	-149.67	-107.33
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-44.57%	-51.60%	-87.88%	-63.50%	-95.29%	-51.15%
Free Cash Flow Per Share	-3.37	-6.89	-15.10	-12.18	-27.42	-21.40
Levered Free Cash Flow	-29.67	-49.43	-77.09	-39.95	-101.35	-58.64
Unlevered Free Cash Flow	-9.02	-31.32	-60.07	-25.87	-86.54	-43.14
Cash Interest Paid	-	14.38	38.6	21.23	34.45	15.54
Change in Working Capital	24.87	28.27	-0.3	31.42	-19.99	-23.19

SEC Filings: 10-K · 10-Q